Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03761056 |
|---|---|
| Brief Title: | Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Participants With High-Risk Large B-Cell Lymphoma (ZUMA-12) |
| First Submitted : | November 29, 2018 |
| First Submitted that Met QC Criteria : | November 29, 2018 |
| First Posted : | December 3, 2018 |
| Results First Submitted : | May 16, 2022 |
| Results First Posted with QC Comments : | June 13, 2022 |
| Results First Submitted that Met QC Criteria : | July 4, 2022 |
| Results First Posted : | July 8, 2022 |
| Last Update Submitted that Met QC Criteria : | October 30, 2023 |
| Last Update Posted : | November 2, 2023 |